FSD Pharma Inc. (HUGE): Price and Financial Metrics


FSD Pharma Inc. (HUGE): $0.88

0.00 (0.30%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

HUGE Stock Price Chart Interactive Chart >

Price chart for HUGE

HUGE Price/Volume Stats

Current price $0.88 52-week high $1.30
Prev. close $0.88 52-week low $0.69
Day low $0.84 Volume 18,200
Day high $0.89 Avg. volume 99,491
50-day MA $0.87 Dividend yield N/A
200-day MA $0.91 Market Cap 33.79M

FSD Pharma Inc. (HUGE) Company Bio


FSD Pharma Inc., through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for central nervous system disorders and autoimmune diseases of the skin, GI tract, and musculoskeletal system, such as chronic pain. FSD Pharma Inc. has strategic alliance agreements with SciCann Therapeutics Inc., CannTab Therapeutics, and Solarvest BioEnergy Inc. The company was founded in 1998 and is headquartered in Toronto, Canada.


HUGE Latest News Stream


Event/Time News Detail
Loading, please wait...

HUGE Latest Social Stream


Loading social stream, please wait...

View Full HUGE Social Stream

Latest HUGE News From Around the Web

Below are the latest news stories about FSD PHARMA INC that investors may wish to consider to help them evaluate HUGE as an investment opportunity.

FSD Pharma Announces Changes to the Board of Directors

TORONTO, November 28, 2022--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, is pleased to announce the appointments of Dr. Lakshmi P. Kotra and Mr. Joseph L. Romano to its Board of Directors, effective November 25, 2022. Effective at the same time was the resignation of Fernando Cugliari from the Board o

Yahoo | November 28, 2022

InvestmentPitch Media Video Discusses FSD Pharma’s Announcement that the Claim for US$30.2 Million Brought by Dr. Raza Bokhari, the Company’s Former CEO, has been Dismissed in its Entirety

VANCOUVER, British Columbia, Nov. 15, 2022 (GLOBE NEWSWIRE) -- FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FSE:0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, reported that the claim for US$30.2 million brought by Dr. Raza Bokhari, the company’s former CEO, has been dismissed. Dr. Bokhari’s claim that he had been wrongfully dismissed has been dismissed it in its entirety by the arbitra

Yahoo | November 15, 2022

FSD Pharma Announces Arbitrator Dismisses Claims by Former CEO, Dr. Raza Bokhari

TORONTO, November 10, 2022--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, today announced that the claim for USD $30.2 million brought by the Company’s former CEO, Dr. Raza Bokhari, was dismissed yesterday, November 9, 2022. Dr. Bokhari had claimed that he had been wrongfully dismissed. The arbitrator h

Yahoo | November 10, 2022

FSD Pharma receives Nasdaq minimum bid price deficiency notification

FSD Pharma (HUGE) received Nasdaq notification stating the company is not in compliance with the minimum bid price requirement. The company’s class B subordinate voting shares…

Seeking Alpha | September 29, 2022

FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

TORONTO — FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRE: 0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, today announced that on September 27, 2022 it received a written notification (the “Notification Letter”) from the Nasdaq Stock […]

Financial Post | September 29, 2022

Read More 'HUGE' Stories Here

HUGE Price Returns

1-mo -2.65%
3-mo -0.10%
6-mo -12.00%
1-year -23.48%
3-year -82.00%
5-year -82.49%
YTD -13.73%
2021 -34.62%
2020 -71.26%
2019 -87.37%
2018 755.60%
2017 -49.90%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7697 seconds.